MEDPACE HOLDINGS INC (MEDP) Stock Fundamental Analysis
NASDAQ:MEDP • US58506Q1094
428.03 USD
+11.99 (+2.88%)
At close: Feb 13, 2026
428.03 USD
0 (0%)
After Hours: 2/13/2026, 8:23:52 PM
Overall MEDP gets a fundamental rating of 7 out of 10. We evaluated MEDP against 58 industry peers in the Life Sciences Tools & Services industry. MEDP scores excellent points on both the profitability and health parts. This is a solid base for a good stock. MEDP is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make MEDP a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
- MEDP had positive earnings in the past year.
- MEDP had a positive operating cash flow in the past year.
- MEDP had positive earnings in each of the past 5 years.
- In the past 5 years MEDP always reported a positive cash flow from operatings.
1.2 Ratios
- MEDP's Return On Assets of 22.84% is amongst the best of the industry. MEDP outperforms 98.28% of its industry peers.
- The Return On Equity of MEDP (98.27%) is better than 100.00% of its industry peers.
- MEDP's Return On Invested Capital of 71.19% is amongst the best of the industry. MEDP outperforms 100.00% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for MEDP is significantly above the industry average of 12.42%.
- The 3 year average ROIC (49.20%) for MEDP is below the current ROIC(71.19%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 22.84% | ||
| ROE | 98.27% | ||
| ROIC | 71.19% |
ROA(3y)19.71%
ROA(5y)17.64%
ROE(3y)65.94%
ROE(5y)56.06%
ROIC(3y)49.2%
ROIC(5y)40.37%
1.3 Margins
- MEDP's Profit Margin of 17.83% is amongst the best of the industry. MEDP outperforms 91.38% of its industry peers.
- MEDP's Profit Margin has improved in the last couple of years.
- The Operating Margin of MEDP (21.14%) is better than 89.66% of its industry peers.
- In the last couple of years the Operating Margin of MEDP has grown nicely.
- MEDP's Gross Margin of 30.06% is on the low side compared to the rest of the industry. MEDP is outperformed by 74.14% of its industry peers.
- In the last couple of years the Gross Margin of MEDP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.14% | ||
| PM (TTM) | 17.83% | ||
| GM | 30.06% |
OM growth 3Y3.46%
OM growth 5Y3.23%
PM growth 3Y2.01%
PM growth 5Y2.64%
GM growth 3Y0.5%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MEDP is creating value.
- The number of shares outstanding for MEDP has been reduced compared to 1 year ago.
- The number of shares outstanding for MEDP has been reduced compared to 5 years ago.
- MEDP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- MEDP has an Altman-Z score of 6.27. This indicates that MEDP is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 6.27, MEDP belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
- MEDP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 6.27 |
ROIC/WACC6.61
WACC10.77%
2.3 Liquidity
- A Current Ratio of 0.74 indicates that MEDP may have some problems paying its short term obligations.
- The Current ratio of MEDP (0.74) is worse than 94.83% of its industry peers.
- MEDP has a Quick Ratio of 0.74. This is a bad value and indicates that MEDP is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.74, MEDP is doing worse than 93.10% of the companies in the same industry.
- The current and quick ratio evaluation for MEDP is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
- MEDP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.14%, which is quite impressive.
- Measured over the past years, MEDP shows a very strong growth in Earnings Per Share. The EPS has been growing by 31.30% on average per year.
- The Revenue has grown by 19.97% in the past year. This is quite good.
- MEDP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.27% yearly.
EPS 1Y (TTM)21.14%
EPS 3Y27.86%
EPS 5Y31.3%
EPS Q2Q%27.25%
Revenue 1Y (TTM)19.97%
Revenue growth 3Y20.12%
Revenue growth 5Y22.27%
Sales Q2Q%32.03%
3.2 Future
- Based on estimates for the next years, MEDP will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.29% on average per year.
- Based on estimates for the next years, MEDP will show a quite strong growth in Revenue. The Revenue will grow by 10.47% on average per year.
EPS Next Y9.87%
EPS Next 2Y10.52%
EPS Next 3Y10.19%
EPS Next 5Y10.29%
Revenue Next Year11.99%
Revenue Next 2Y10.2%
Revenue Next 3Y11.36%
Revenue Next 5Y10.47%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 27.98, which means the current valuation is very expensive for MEDP.
- Compared to the rest of the industry, the Price/Earnings ratio of MEDP indicates a somewhat cheap valuation: MEDP is cheaper than 68.97% of the companies listed in the same industry.
- MEDP is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.97, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 25.46, the valuation of MEDP can be described as expensive.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of MEDP indicates a somewhat cheap valuation: MEDP is cheaper than 72.41% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 27.96. MEDP is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.98 | ||
| Fwd PE | 25.46 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, MEDP is valued a bit cheaper than the industry average as 70.69% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, MEDP is valued cheaper than 87.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.68 | ||
| EV/EBITDA | 19.93 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The excellent profitability rating of MEDP may justify a higher PE ratio.
PEG (NY)2.83
PEG (5Y)0.89
EPS Next 2Y10.52%
EPS Next 3Y10.19%
5. Dividend
5.1 Amount
- No dividends for MEDP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
428.03
+11.99 (+2.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-09 2026-02-09/amc
Earnings (Next)04-20 2026-04-20/amc
Inst Owners87.1%
Inst Owner Change-0.63%
Ins Owners0.44%
Ins Owner Change-6.05%
Market Cap12.06B
Revenue(TTM)2.53B
Net Income(TTM)451.12M
Analysts52.22
Price Target557.47 (30.24%)
Short Float %6.04%
Short Ratio5.75
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.54%
Min EPS beat(2)7.52%
Max EPS beat(2)9.56%
EPS beat(4)4
Avg EPS beat(4)9.37%
Min EPS beat(4)2.57%
Max EPS beat(4)17.84%
EPS beat(8)8
Avg EPS beat(8)12.36%
EPS beat(12)11
Avg EPS beat(12)11.35%
EPS beat(16)15
Avg EPS beat(16)14.34%
Revenue beat(2)2
Avg Revenue beat(2)0.84%
Min Revenue beat(2)0.75%
Max Revenue beat(2)0.93%
Revenue beat(4)4
Avg Revenue beat(4)3.88%
Min Revenue beat(4)0.75%
Max Revenue beat(4)9.78%
Revenue beat(8)4
Avg Revenue beat(8)0.78%
Revenue beat(12)7
Avg Revenue beat(12)1.31%
Revenue beat(16)10
Avg Revenue beat(16)1.28%
PT rev (1m)1.27%
PT rev (3m)7.24%
EPS NQ rev (1m)0.02%
EPS NQ rev (3m)-0.09%
EPS NY rev (1m)0%
EPS NY rev (3m)5.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.98 | ||
| Fwd PE | 25.46 | ||
| P/S | 4.77 | ||
| P/FCF | 17.68 | ||
| P/OCF | 16.91 | ||
| P/B | 26.27 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.93 |
EPS(TTM)15.3
EY3.57%
EPS(NY)16.81
Fwd EY3.93%
FCF(TTM)24.21
FCFY5.66%
OCF(TTM)25.32
OCFY5.92%
SpS89.82
BVpS16.3
TBVpS-8.4
PEG (NY)2.83
PEG (5Y)0.89
Graham Number74.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 22.84% | ||
| ROE | 98.27% | ||
| ROCE | 84.68% | ||
| ROIC | 71.19% | ||
| ROICexc | 333.94% | ||
| ROICexgc | N/A | ||
| OM | 21.14% | ||
| PM (TTM) | 17.83% | ||
| GM | 30.06% | ||
| FCFM | 26.95% |
ROA(3y)19.71%
ROA(5y)17.64%
ROE(3y)65.94%
ROE(5y)56.06%
ROIC(3y)49.2%
ROIC(5y)40.37%
ROICexc(3y)169.04%
ROICexc(5y)114.84%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)58.52%
ROCE(5y)48.87%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y101.11%
ROICexc growth 5Y74.12%
OM growth 3Y3.46%
OM growth 5Y3.23%
PM growth 3Y2.01%
PM growth 5Y2.64%
GM growth 3Y0.5%
GM growth 5Y-0.03%
F-Score7
Asset Turnover1.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.49% | ||
| Cap/Sales | 1.24% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 126.67% | ||
| Profit Quality | 151.15% | ||
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | 6.27 |
F-Score7
WACC10.77%
ROIC/WACC6.61
Cap/Depr(3y)125.21%
Cap/Depr(5y)134.9%
Cap/Sales(3y)1.64%
Cap/Sales(5y)1.98%
Profit Quality(3y)144.35%
Profit Quality(5y)141.17%
High Growth Momentum
Growth
EPS 1Y (TTM)21.14%
EPS 3Y27.86%
EPS 5Y31.3%
EPS Q2Q%27.25%
EPS Next Y9.87%
EPS Next 2Y10.52%
EPS Next 3Y10.19%
EPS Next 5Y10.29%
Revenue 1Y (TTM)19.97%
Revenue growth 3Y20.12%
Revenue growth 5Y22.27%
Sales Q2Q%32.03%
Revenue Next Year11.99%
Revenue Next 2Y10.2%
Revenue Next 3Y11.36%
Revenue Next 5Y10.47%
EBIT growth 1Y19.71%
EBIT growth 3Y24.28%
EBIT growth 5Y26.22%
EBIT Next Year13.88%
EBIT Next 3Y12.83%
EBIT Next 5Y12.46%
FCF growth 1Y19.15%
FCF growth 3Y24.75%
FCF growth 5Y24.56%
OCF growth 1Y17.15%
OCF growth 3Y22.49%
OCF growth 5Y22.49%
MEDPACE HOLDINGS INC / MEDP FAQ
What is the fundamental rating for MEDP stock?
ChartMill assigns a fundamental rating of 7 / 10 to MEDP.
Can you provide the valuation status for MEDPACE HOLDINGS INC?
ChartMill assigns a valuation rating of 5 / 10 to MEDPACE HOLDINGS INC (MEDP). This can be considered as Fairly Valued.
What is the profitability of MEDP stock?
MEDPACE HOLDINGS INC (MEDP) has a profitability rating of 9 / 10.
What are the PE and PB ratios of MEDPACE HOLDINGS INC (MEDP) stock?
The Price/Earnings (PE) ratio for MEDPACE HOLDINGS INC (MEDP) is 27.98 and the Price/Book (PB) ratio is 26.27.
How financially healthy is MEDPACE HOLDINGS INC?
The financial health rating of MEDPACE HOLDINGS INC (MEDP) is 8 / 10.